1 | LLY | Eli Lilly and Company | 10.02% |
2 | DHR | Danaher Corporation | 5.90% |
3 | ADMA | ADMA Biologics, Inc. | 5.00% |
4 | PCT | PureCycle Technologies, Inc. | 4.77% |
5 | GILD | Gilead Sciences, Inc. | 4.51% |
6 | ARQT | Arcutis Biotherapeutics, Inc. | 4.27% |
7 | INSM | Insmed Incorporated | 4.15% |
8 | PM | Philip Morris International Inc. | 4.00% |
9 | ISRG | Intuitive Surgical, Inc. | 3.46% |
10 | EYE | National Vision Holdings, Inc. | 3.06% |
11 | CAH | Cardinal Health, Inc. | 2.91% |
12 | WGS | GeneDx Holdings Corp. | 2.83% |
13 | FLR | Fluor Corporation | 2.80% |
14 | ABBV | AbbVie Inc. | 2.73% |
15 | NBIX | Neurocrine Biosciences, Inc. | 2.53% |
16 | CVS | CVS Health Corporation | 2.46% |
17 | PCRX | Pacira BioSciences, Inc. | 2.27% |
18 | COR | Cencora, Inc. | 2.01% |
19 | RMD | ResMed Inc. | 1.94% |
20 | AZN | AstraZeneca PLC | 1.87% |
21 | Cash | Cash | 1.58% |
22 | REGN | Regeneron Pharmaceuticals, Inc. | 1.52% |
23 | ALHC | Alignment Healthcare, Inc. | 1.39% |
24 | GEHC | GE HealthCare Technologies Inc. | 1.39% |
25 | DXCM | DexCom, Inc. | 1.31% |
View PINK holdings |